+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Herpes Marker Testing Market by Test Type, Technology, End User, Distribution Channel - Global Forecast to 2030- Product Image
Herpes Marker Testing Market by Test Type, Technology, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Herpes Marker Testing Market by Test Type, Technology, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887707
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The herpes marker testing market is evolving rapidly, shaped by technological advancements, regulatory shifts, and increasing demand for accurate and accessible diagnostic solutions. Senior stakeholders require actionable insights that capture market complexity and outline strategic opportunities across development, adoption, and commercialization.

Market Snapshot: Herpes Marker Testing Market Overview

The Herpes Marker Testing Market grew from USD 497.86 million in 2024 to USD 531.76 million in 2025. It is expected to continue growing at a CAGR of 6.49%, reaching USD 726.32 million by 2030.

Growth is driven by rising awareness of herpes infections, ongoing investments in diagnostic innovation, and the push for faster, cost-effective lab procedures. The competitive landscape includes longstanding diagnostics leaders and emerging specialist firms, each adapting to changes in regulatory policies and healthcare delivery models.

Scope & Segmentation of the Herpes Marker Testing Market

  • Test Types: Combined HSV-1 & HSV-2 antibody assays, HSV-1-specific tests, and HSV-2-specific tests.
  • Technology Modalities: ELISA (IgG, IgM), PCR (conventional, real-time), rapid tests (lateral flow assay, latex agglutination), Western blot.
  • End Users: Clinics (general and specialized), diagnostic laboratories (hospital labs and independent labs), hospitals, research institutes.
  • Distribution Channels: Direct tender (government, institutional), hospital pharmacies, online pharmacies (company websites, e-commerce platforms), retail pharmacies.
  • Regions Covered: Americas (including specific U.S. states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the UK, Germany, France, Russia, major Middle Eastern and African markets), Asia-Pacific (China, India, Japan, Australia, South Korea, ASEAN nations, and others).
  • Key Companies Profiled: F. Hoffmann-La Roche AG, Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Danaher Corporation, bioMérieux SA, Qiagen NV, Becton Dickinson and Company, DiaSorin S.p.A., Bio-Rad Laboratories, Inc.

Key Takeaways for Herpes Marker Testing Market Decision-Makers

  • Multiplex diagnostics and digital health integrations now allow laboratories to accelerate result delivery and reduce manual handling, improving both efficiency and workflow transparency.
  • The convergence of immunoassays, molecular diagnostics, and point-of-care technologies is prompting established firms to adapt portfolios and align with shifting clinical protocols.
  • Strong partnerships between assay developers and research institutes are driving the identification of novel biomarker targets, supporting a robust new product pipeline.
  • Regional adoption rates are influenced by variations in healthcare infrastructure and reimbursement models, requiring localized market entry strategies.
  • Development of resilient, localized supply chains is becoming essential amid trade policy changes and raw material cost pressures.
  • Continuous investment in R&D, automation, and digital reporting supports long-term competitiveness and aligns with clinical validation requirements.

Tariff Impact and Supply Chain Realignment

With 2025 U.S. tariff changes taking effect, manufacturers face increased costs for imported components, notably in diagnostic kit assembly and instrumentation. Firms are responding by near-shoring production, revising supplier contracts, and seeking tariff-exempt sourcing to shield laboratories and clinical end-users from steep price fluctuations. These actions are expected to foster regional manufacturing capabilities and reinforce supply chain resilience, even as capital expenditures may temporarily rise. End users are increasingly engaging in joint procurement and longer-term purchasing agreements to enhance budget predictability.

Methodology & Data Sources

Findings rely on a combination of secondary research—including peer-reviewed journals, regulatory filings, and industry reports—and primary data from interviews with clinical virologists, laboratory directors, and procurement managers. Structured surveys with diagnostic manufacturers and end users provided depth on pricing and capacity trends. Data verification involved triangulation methods, scenario testing, and peer review to ensure analytic rigor throughout segmentation and forecasting.

Why This Report Matters for Herpes Marker Testing

  • Delivers a clear view of segment-specific trends, allowing business leaders to align R&D and portfolio strategy with real-world clinical workflows.
  • Equips stakeholders to navigate evolving tariff landscapes, supporting well-informed procurement and supply chain planning.
  • Offers actionable insight on competitive positioning and emerging partnership models in the rapidly evolving diagnostics ecosystem.

Conclusion

Herpes marker testing is entering a pivotal phase as diagnostic technologies, regulatory frameworks, and supply chain strategies reshape the market's potential. Leaders positioned to act on segment trends, partnership opportunities, and operational shifts can achieve significant, sustainable growth in this dynamic environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Herpes Marker Testing Market, by Test Type
8.1. Introduction
8.2. Combined
8.3. Hsv-1
8.4. Hsv-2
9. Herpes Marker Testing Market, by Technology
9.1. Introduction
9.2. Elisa
9.2.1. Igg Elisa
9.2.2. Igm Elisa
9.3. Pcr
9.3.1. Conventional Pcr
9.3.2. Real-Time Pcr
9.4. Rapid Test
9.4.1. Lateral Flow Assay
9.4.2. Latex Agglutination
9.5. Western Blot
10. Herpes Marker Testing Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. General Clinics
10.2.2. Specialized Clinics
10.3. Diagnostic Laboratories
10.3.1. Hospital Labs
10.3.2. Independent Laboratories
10.4. Hospitals
10.5. Research Institutes
11. Herpes Marker Testing Market, by Distribution Channel
11.1. Introduction
11.2. Direct Tender
11.2.1. Government Tender
11.2.2. Institutional Tender
11.3. Hospital Pharmacies
11.4. Online Pharmacies
11.4.1. Company Websites
11.4.2. E-Commerce Platforms
11.5. Retail Pharmacies
12. Americas Herpes Marker Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Herpes Marker Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Herpes Marker Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. F. Hoffmann-La Roche AG
15.3.2. Abbott Laboratories
15.3.3. Thermo Fisher Scientific Inc.
15.3.4. Siemens Healthineers AG
15.3.5. Danaher Corporation
15.3.6. bioMérieux SA
15.3.7. Qiagen NV
15.3.8. Becton Dickinson and Company
15.3.9. DiaSorin S.p.A.
15.3.10. Bio-Rad Laboratories, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. HERPES MARKER TESTING MARKET MULTI-CURRENCY
FIGURE 2. HERPES MARKER TESTING MARKET MULTI-LANGUAGE
FIGURE 3. HERPES MARKER TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL HERPES MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HERPES MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HERPES MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. HERPES MARKER TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HERPES MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COMBINED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HSV-1, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HSV-2, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY IGG ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY IGM ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY CONVENTIONAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY LATEX AGGLUTINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY GOVERNMENT TENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INSTITUTIONAL TENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 70. CANADA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 71. CANADA HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. CANADA HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 73. CANADA HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 74. CANADA HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 75. CANADA HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. CANADA HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 77. CANADA HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 78. CANADA HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. CANADA HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 80. CANADA HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 81. MEXICO HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. MEXICO HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 84. MEXICO HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 85. MEXICO HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 86. MEXICO HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. MEXICO HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 89. MEXICO HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. MEXICO HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 91. MEXICO HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 137. GERMANY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 138. GERMANY HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. GERMANY HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 140. GERMANY HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 141. GERMANY HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 142. GERMANY HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. GERMANY HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 144. GERMANY HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 145. GERMANY HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. GERMANY HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 147. GERMANY HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 148. FRANCE HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 149. FRANCE HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. FRANCE HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 151. FRANCE HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 152. FRANCE HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 153. FRANCE HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. FRANCE HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 155. FRANCE HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 156. FRANCE HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. FRANCE HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 158. FRANCE HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 170. ITALY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 171. ITALY HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. ITALY HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 173. ITALY HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 174. ITALY HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 175. ITALY HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. ITALY HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 177. ITALY HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 178. ITALY HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. ITALY HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 180. ITALY HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 181. SPAIN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 182. SPAIN HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. SPAIN HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 184. SPAIN HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 185. SPAIN HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 186. SPAIN HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. SPAIN HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 188. SPAIN HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 189. SPAIN HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. SPAIN HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 191. SPAIN HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 225. DENMARK HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 226. DENMARK HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. DENMARK HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 228. DENMARK HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 229. DENMARK HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 230. DENMARK HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. DENMARK HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 232. DENMARK HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 233. DENMARK HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. DENMARK HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 235. DENMARK HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 247. QATAR HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 248. QATAR HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. QATAR HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 250. QATAR HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 251. QATAR HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 252. QATAR HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. QATAR HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 254. QATAR HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 255. QATAR HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. QATAR HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 257. QATAR HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 258. FINLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 259. FINLAND HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. FINLAND HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 261. FINLAND HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 262. FINLAND HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 263. FINLAND HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. FINLAND HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 265. FINLAND HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 266. FINLAND HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. FINLAND HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 268. FINLAND HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 269. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 270. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 271. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 272. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 280. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 291. EGYPT HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 292. EGYPT HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 293. EGYPT HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 294. EGYPT HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 295. EGYPT HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 296. EGYPT HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. EGYPT HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 298. EGYPT HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 299. EGYPT HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. EGYPT HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 301. EGYPT HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 302. TURKEY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 303. TURKEY HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 304. TURKEY HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 305. TURKEY HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 306. TURKEY HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 307. TURKEY HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. TURKEY HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 309. TURKEY HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 310. TURKEY HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. TURKEY HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 312. TURKEY HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 313. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 314. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 316. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 317. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 318. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 320. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 321. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 323. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 324. NORWAY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 325. NORWAY HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 326. NORWAY HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 327. NORWAY HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 328. NORWAY HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 329. NORWAY HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 330. NORWAY HERPES MARKER TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 331. NORWAY HERPES MARKER TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 332. NORWAY HERPES MARKER TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 333. NORWAY HERPES MARKER TESTING MARKET SIZE, BY DIRECT TENDER, 2018-2030 (USD MILLION)
TABLE 334. NORWAY HERPES MARKER TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 335. POLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 336. POLAND HERPES MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 337. POLAND HERPES MARKER TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 338. POLAND HERPES MARKER TESTING MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 339. POLAND HERPES MARKER TESTING MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 340. POLAND HERPES MARKER TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 341. POLAND HERPES MARKER TEST

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Herpes Marker Testing market report include:
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Danaher Corporation
  • bioMérieux SA
  • Qiagen NV
  • Becton Dickinson and Company
  • DiaSorin S.p.A.
  • Bio-Rad Laboratories, Inc.

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 531.76 Million
Forecasted Market Value ( USD ) by 2030 $ 726.32 Million
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Herpes Marker Testing - Global Strategic Business Report - Product Image

Herpes Marker Testing - Global Strategic Business Report

  • Report
  • 159 Pages
  • Global
From
2024-2029 Global Herpes Markers Testing Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities - Product Image

2024-2029 Global Herpes Markers Testing Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • Report
  • Europe, Global, Japan, ... Europe, Global, Japan, United States
From
STD Testing - Global Strategic Business Report - Product Image

STD Testing - Global Strategic Business Report

  • Report
  • 197 Pages
  • Global
From
Sexually Transmitted Disease Diagnostics Market Report by Type, Device Type, End User, and Region 2025-2033 - Product Image

Sexually Transmitted Disease Diagnostics Market Report by Type, Device Type, End User, and Region 2025-2033

  • Report
  • 143 Pages
  • Global
From
Sexually Transmitted Disease Diagnostics Market by Diagnostic Test Types, Pathogen Types, End-User Types, Sample Types, Technology Types, Product Types - Global Forecast to 2030 - Product Image

Sexually Transmitted Disease Diagnostics Market by Diagnostic Test Types, Pathogen Types, End-User Types, Sample Types, Technology Types, Product Types - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.